2023-10-11 15:30:53
Installed at the heart of the JFIC-CAT 2023, we asked Charlotte Puel, cardiologist, and Peggy Jacon, rhythmologist, to come to our set to discuss the defibrillator vest as part of the updating of the ESC recommendations regarding management of heart failure.
How, from a rhythmic point of view, should we manage patients when heart failure with reduced LVEF is discovered? According to data from the STRONG-HF study, which recommends rapid drug titration in cases of heart failure with impaired ejection fraction, is it still wise to wait the theoretical 3 months before discussing the implantation of a defibrillator? Once the defibrillator vest is removed, should we continue to regularly reassess patients rhythmically?
Follow this exchange to get valuable answers!
All the news from JFIC-CAT 2023
This content is brought to you with the institutional support of ZOLL
LifeVest® is a portable defibrillator, class III medical device, (CE0123), manufactured by ZOLL Manufacturing Corp., indicated for the treatment of adult patients at risk of sudden cardiac arrest, and covered by social security if prescribed by centers authorized under the conditions and for the medical indications detailed under the LPPR code 1112161. Please read carefully the indications, contraindications, warnings and instructions for use available on the following site: lifevest.zoll.com/mdr.
1697038820
#place #defibrillator #vest #context #update #ESC #recommendations #management #heart #failure
